Skip to main content
Fig. 1 | Journal of Hematology & Oncology

Fig. 1

From: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology Group

Fig. 1

MEF2C expression in AAML0531. Quantitative expression of MEF2C relative to beta glucuronidase (GUSB) in diagnostic bone marrow specimens from the 751 patients who were included in this study. a Relative MEF2C expression across the entire study cohort. b Distribution of relative MEF2C expression across quartiles of MEF2C expression. c Distribution of relative MEF2C expression across individual cytogenetic categories

Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us